Sweden · Delayed Price · Currency is SEK SpectraCure AB Statistics
Total Valuation
SpectraCure AB has a market cap or net worth of SEK 40.97 million. The enterprise value is 18.86 million.
| Market Cap | 40.97M |
| Enterprise Value | 18.86M |
Important Dates
The next estimated earnings date is Friday, February 20, 2026.
| Earnings Date | Feb 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SpectraCure AB has 409.67 million shares outstanding. The number of shares has increased by 110.83% in one year.
| Current Share Class | 409.67M |
| Shares Outstanding | 409.67M |
| Shares Change (YoY) | +110.83% |
| Shares Change (QoQ) | +298.18% |
| Owned by Insiders (%) | 6.96% |
| Owned by Institutions (%) | 2.99% |
| Float | 380.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.35 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.15, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.15 |
| Quick Ratio | 3.15 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -40.77 |
Financial Efficiency
Return on equity (ROE) is -50.02% and return on invested capital (ROIC) is -29.85%.
| Return on Equity (ROE) | -50.02% |
| Return on Assets (ROA) | -27.79% |
| Return on Invested Capital (ROIC) | -29.85% |
| Return on Capital Employed (ROCE) | -51.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.09M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SpectraCure AB has paid 25,000 in taxes.
| Income Tax | 25,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.85% in the last 52 weeks. The beta is 0.51, so SpectraCure AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -95.85% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.40 |
| Relative Strength Index (RSI) | 27.08 |
| Average Volume (20 Days) | 2,263,771 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | 10.45M |
| Operating Income | -52.92M |
| Pretax Income | -53.14M |
| Net Income | -53.17M |
| EBITDA | -24.96M |
| EBIT | -52.92M |
| Earnings Per Share (EPS) | -0.26 |
Balance Sheet
The company has 25.51 million in cash and 3.40 million in debt, with a net cash position of 22.11 million or 0.05 per share.
| Cash & Cash Equivalents | 25.51M |
| Total Debt | 3.40M |
| Net Cash | 22.11M |
| Net Cash Per Share | 0.05 |
| Equity (Book Value) | 101.11M |
| Book Value Per Share | 0.25 |
| Working Capital | 19.98M |
Cash Flow
| Operating Cash Flow | -24.60M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SpectraCure AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -110.83% |
| Shareholder Yield | -110.83% |
| Earnings Yield | -129.78% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |